000 01065 a2200325 4500
005 20250513151104.0
264 0 _c19981102
008 199811s 0 0 eng d
022 _a0012-6667
024 7 _a10.2165/00003495-199856020-00010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarkham, A
245 0 0 _aMontelukast.
_h[electronic resource]
260 _bDrugs
_cAug 1998
300 _a251-6; discussion 257 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Review
650 0 4 _aAcetates
_xpharmacokinetics
650 0 4 _aAdult
650 0 4 _aAnti-Asthmatic Agents
_xpharmacokinetics
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aChild
650 0 4 _aCyclopropanes
650 0 4 _aDrug Tolerance
650 0 4 _aHumans
650 0 4 _aQuinolines
_xpharmacokinetics
650 0 4 _aSulfides
700 1 _aFaulds, D
773 0 _tDrugs
_gvol. 56
_gno. 2
_gp. 251-6; discussion 257
856 4 0 _uhttps://doi.org/10.2165/00003495-199856020-00010
_zAvailable from publisher's website
999 _c9677033
_d9677033